CELL & GENE THERAPY INSIGHTS

Global regulatory update

Guest Editor:
Alexis Cockroft, Regulatory Consultant at Lex Regulatory Ltd
Alexis Cockroft
Regulatory Consultant at Lex Regulatory Ltd
July 2022